INGN Q4 2021 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$76M+3.3% YoY

Gross Profit

$39M50.5% margin

Operating Income

-$7M-8.7% margin

Net Income

-$23M-29.9% margin

EPS (Diluted)

$-1.01

QoQ Revenue Growth

-17.9%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$526,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$490M

Total Liabilities

$119M

Stockholders' Equity

$370M

Cash & Equivalents

$236M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$74M	+3.3%
Gross Profit	$39M	$34M	+13.3%
Operating Income	-$7M	-$6M	-20.8%
Net Income	-$23M	-$5M	-346.7%

Geographic Segments

UNITED STATES

$56M74%

Non Us

$20M26%